First Time Loading...
H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 211 500 KRW -4.3%
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Hugel Inc stock under the Base Case scenario is 228 898.59 KRW. Compared to the current market price of 211 500 KRW, Hugel Inc is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
228 898.59 KRW
Undervaluation 8%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
54
vs Industry
56
Median 3Y
6
Median 5Y
7.7
Industry
8.1
Forward
6
More Details
24.8
P/E
P/E
Price to Earnings
24.8
vs History
66
vs Industry
7
Median 3Y
24.2
Median 5Y
28
Industry
26.2
Forward
24.6
More Details
19.6
P/OCF
P/OCF
Price to OCF
19.6
vs History
64
vs Industry
9
Median 3Y
18.9
Median 5Y
21.1
Industry
22.6
More Details
30.6
P/FCFE
P/FCFE
Price to FCFE
30.6
vs History
80
vs Industry
5
Median 3Y
45.9
Median 5Y
45.8
Industry
21.3
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
16
vs Industry
31
Median 3Y
2.1
Median 5Y
2.3
Industry
2.5
More Details
6
EV/S
EV/S
Enterprise Value to Sales
6
vs History
41
vs Industry
51
Median 3Y
4.2
Median 5Y
5.5
Industry
7.3
Forward
5
More Details
7.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.8
vs History
48
vs Industry
48
Median 3Y
5.5
Median 5Y
7.6
Industry
9.1
More Details
14.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.6
vs History
38
vs Industry
8
Median 3Y
9.9
Median 5Y
13.5
Industry
4.4
Forward
12.5
More Details
16.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.3
vs History
38
vs Industry
8
Median 3Y
11.5
Median 5Y
15
Industry
4.3
Forward
13
More Details
16.3
EV/OCF
EV/OCF
Enterprise Value to OCF
16.3
vs History
38
vs Industry
9
Median 3Y
12.9
Median 5Y
15.3
Industry
5.4
More Details
24.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.9
vs History
62
vs Industry
6
Median 3Y
30.1
Median 5Y
29.1
Industry
3.2
More Details
4.3
EV/IC
EV/IC
Enterprise Value to IC
4.3
vs History
25
vs Industry
35
Median 3Y
2.5
Median 5Y
3.5
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Hugel Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Hugel Inc
KOSDAQ:145020
2.3T KRW 7.2 24.8 14.6 16.3
US
Abbvie Inc
NYSE:ABBV
288.7B USD 5.3 59.9 13 19.8
US
Amgen Inc
NASDAQ:AMGN
147.9B USD 5.2 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103B USD 10.4 28.5 22.8 23.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.5B USD 7.5 24.9 16.5 18.2
AU
CSL Ltd
ASX:CSL
132.6B AUD 6.1 35 21.2 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 14.4 7.9 10.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
41.7B USD 6.1 -8.8 -9.3 -7.9
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 27 14.6 18.1
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.